血管阻抗 的英文怎麼說

中文拼音 [xiěguǎnzǔkàng]
血管阻抗 英文
vascular hindrance
  • 血 : 血名詞（血液 多用於口語） blood:吐血 spit （up） blood; 血的教訓 a lesson paid for [written] in b...
  • 管 : Ⅰ名詞1 （管子） pipe; tube 2 （吹奏的樂器） wind musical instrument 3 （形狀似管的電器件） valve;...
  • 阻 : 動詞（阻擋; 阻礙） block; hinder; impede; obstruct
  • 抗 : Ⅰ動詞1 （抵抗; 抵擋） resist; combat; fight 2 （拒絕; 抗拒） refuse; defy 3 （對等） contend with...
  • 血管 : blood vessel; vascellum; vessel; rete
  • 阻抗 : [電學] impedance
  1. Among antihypertensive measures, blockade of the raas by means of ace inhibitors or angiotensin ii receptor antagonists recently emerged as a potentially polyvalent approach, not only for treating hypertension and reducing cardiovascular events, but also to prevent or reduce albuminuria, counteract diabetic nephropathy and lower the occurrence of new type 2 diabetes in individuals at risk

    在抗高血壓藥物治療中，通過用ace抑制劑或血管緊張素受體拮抗劑可阻滯腎素-血管緊張素-醛固酮系統激活，最近其可作為一種潛在多能的治療方法，不僅可治療高血壓和減少心血管事件，也能夠預防或減少蛋白尿，阻止糖尿病性腎病變，並使新糖尿病患者發生風險性降得更低。
  2. So far, six kinds of medicines are authorised to be applied to the treatment of hypertension by the world health organization ( who ), including diuretics, - receptor blocking agent, - receptor blocking agent, angiotensin receptor antagon, calcium channal blocking agent and angiotensin converting enzyme inhibitors ( aceis )

    目前，世界衛生組織（ who ）批準用於治療高血壓病的一線藥物主要有利尿劑、受體阻斷劑、血管緊張素轉換酶抑制劑（ acei ） 、鈣通道阻滯劑（ caa ） 、受體阻斷劑、血管緊張素（ ang ）受體拮抗劑等六大類。
  3. Methods : the action of antiinflammation of ytk was observed through granulomas of rats caused by cotton, the models of the salpingitic block of rats caused by potassium paste were made to observe the opponens action of ytk and the effect on hemorheology

    方法：以大鼠棉球肉芽腫實驗觀察炎痛克貼劑的抗炎作用；以苯酚糊劑造實驗性大鼠輸卵管炎性阻塞模型，觀察炎痛克貼劑的對抗作用及對血液流變學的影響。
  4. Anti - coagulants are 5 ) pumped into the blood to stop it from 6 ) clotting and the heart is kept pumping until the 7 ) technicians are sure that the chemicals have passed through every 8 ) vein and into the brain

    一在血液中打入抗凝血劑以阻止血液凝結，心臟也持續抽送血液，直到技術人員確定化學藥物已經通過所有血管並進入腦部。
  5. " the concept is that systemic sclerosis, which is a severe disease characterized by systemic fibrosis, is at the beginning mainly a vascular disease, and we hypothesize that using major vascular drugs ( calcium channel blockers, endothelin antagonists, prostacyclins, phosphodiesterase inhibitors, etc. ) from the beginning and at appropriate dosage may interfere with the fibrotic process which seems secondary, " dr

    「從概念上講，系統性硬化是一種以系統性的纖維化變性為特徵的嚴重疾病，早期主要表現在血管性的病變，因此我們推測早期、適量地應用主要作用於血管的藥物（如鈣離子阻斷劑，內皮素拮抗劑，前列環素，磷酸二酯酶抑制劑等）可能可以干預似乎是繼發發生的纖維化過程。 」
  6. " the concept is that systemic sclerosis, which is a seere disease characterized by systemic fibrosis, is at the beginning mainly a ascular disease, and we hypothesize that using major ascular drugs ( calcium channel blockers, endothelin antagonists, prostacyclins, phosphodiesterase inhibitors, etc. ) from the beginning and at appropriate dosage may interfere with the fibrotic process which seems secondary, " dr

    「從概念上講，系統性硬化是一種以系統性的纖維化變性為特徵的嚴重疾病，早期主要表現在血管性的病變，因此我們推測早期、適量地應用主要作用於血管的藥物（如鈣離子阻斷劑，內皮素拮抗劑，前列環素，磷酸二酯酶抑制劑等）可能可以干預似乎是繼發發生的纖維化過程。 」
  7. In this manner, angiostatin inhibits the growth of primary and metastatic tumors in vivo. it is a promising drug for angiogenesis - dependent diseases especially in pre - clinical and clinical cancer trials

    As可以阻抑血管生成治療由病理性血管形成而導致的疾病，尤其是可通過抗腫瘤新生血管生成抑制腫瘤的生長與轉移，有重要的臨床應用價值。
  8. At discharge, 86 % of patients were receiving beta blockers and 76 % were receiving either ace inhibitors of angiotensin receptor blockers

    在出院的時， 86 %的患者服用受體阻滯劑，而76 %的患者服用ace抑制劑或者血管緊張素受體拮抗劑。
  9. " anti - angiogenic " cancer therapies that focus on the tumor ' s blood supply are not new

    很早以前抗血管生成腫瘤治療策略主要目的是阻斷腫瘤的血液供應。
  10. The ability to target psma on blood essels would proide a way to directly attack a tumor ' s blood supply without affecting normal blood essels

    因此特異針對血管的psma抗原可以在腫瘤治療時直接阻斷腫瘤的血液供應，而不影響正常血管的功能。
  11. Comparison of several lumped - parameter models to simulate the input impedance in systemic circulation

    心血管系統體循環輸入阻抗的幾種集中參數模型的比較和應用
  12. To construct geometric models, the main stem and the branches of coronary artery are assumed to develop along the surface of a sphere which simulates a heart body so as to obtain more accurate spatial 3d asymmetric descriptive models for the simulation of the coronary artery

    研究認為血管作為人體的組織器官，是幾十億年的生物進化的結果。近20年來，人們普遍接受的原理主要有：最小能耗原理：最小阻抗原理；最小容量原理。
分享友人
分享到 Line

分享到臉書